BUILT TO LAST Trademark

Trademark Overview


On Tuesday, September 15, 2020, a trademark application was filed for BUILT TO LAST with the United States Patent and Trademark Office. The USPTO has given the BUILT TO LAST trademark a serial number of 90182586. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, May 6, 2022. This trademark is owned by Bristol-Myers Squibb Company. The BUILT TO LAST trademark is filed in the Pharmaceutical Products, Paper & Printed Material Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pha...

Printed matter, namely, magazines, books, booklets, brochures, pamphlets, newsletters and catalogs in the field of pharmaceutical preparations for the treatment of cancer

Medical information services, namely, providing medical information to physicians, health care professionals, and patients on the topic of cancer
built to last

General Information


Serial Number90182586
Word MarkBUILT TO LAST
Filing DateTuesday, September 15, 2020
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, May 6, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 14, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for use in disease testing
Goods and ServicesPrinted matter, namely, magazines, books, booklets, brochures, pamphlets, newsletters and catalogs in the field of pharmaceutical preparations for the treatment of cancer
Goods and ServicesMedical information services, namely, providing medical information to physicians, health care professionals, and patients on the topic of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code6 - Active
Class Status DateThursday, October 22, 2020
Primary Code016
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 22, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events


Event DateEvent Description
Tuesday, May 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 6, 2022SOU EXTENSION 1 GRANTED
Friday, May 6, 2022SOU EXTENSION 1 FILED
Friday, May 6, 2022TEAS EXTENSION RECEIVED
Tuesday, November 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021PUBLISHED FOR OPPOSITION
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 5, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, August 5, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 5, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, August 5, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, July 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 1, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 1, 2021NON-FINAL ACTION E-MAILED
Monday, February 1, 2021NON-FINAL ACTION WRITTEN
Wednesday, January 27, 2021ASSIGNED TO EXAMINER
Thursday, October 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 18, 2020NEW APPLICATION ENTERED IN TRAM